Cerebrospinal Fluid Shunting in Hydrocephalus Secondary to Leptomeningeal Metastases: A Systematic Review and Meta-Analysis of Functional Outcomes, Symptom Improvement, and Complications
Open Access
- 7 March 2026
- journal article
- review article
- Published by Elsevier in World Neurosurgery
- Vol. 209, 124901
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Lumboperitoneal and ventriculoperitoneal shunting for leptomeningeal disease-associated hydrocephalus: a systematic review and meta-analysis of postoperative outcomes and comparative effectivenessNeurological Sciences, 2025
- Managing hydrocephalus in patients with leptomeningeal disease: A multicenter retrospective analysisInternational Journal of Cancer, 2025
- Comparative analysis of the lumboperitoneal shunt versus ventriculoperitoneal shunt for leptomeningeal metastasis-associated hydrocephalus in non-small cell lung cancerActa Neurochirurgica, 2025
- Melanoma brain metastasis presentation, treatment, and outcomes in the age of targeted and immunotherapiesCancer, 2021
- Cerebrospinal fluid diversion and outcomes for lung cancer patients with leptomeningeal carcinomatosisActa Neurochirurgica, 2021
- Management of hydrocephalus in patients with leptomeningeal metastases: an ethical approach to decision-makingJournal of Neuro-Oncology, 2018
- Implications of Screening for Brain Metastases in Patients With Breast Cancer and Non–Small Cell Lung CancerJAMA Oncology, 2018
- Ventriculoperitoneal shunt for hydrocephalus caused by central nervous system metastasisJournal of Neuro-Oncology, 2011
- New Strategies in the Management of Leptomeningeal MetastasesArchives of Neurology, 2010
- Leptomeningeal metastases from small cell lung carcinomaCancer, 2005